
    
      This is a combined analysis using 81 patients randomized and treated in CRAD001A2419
      (NCT00154284) with 33 randomized and treated in CRAD001A2423 (NCT00170807). This approach is
      reflected in the protocol amendments for each study, and the one clinical study report for
      both.
    
  